Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Autor:
Chun-Ming Tsai, Yuh Min Chen, Jacqueline Whang-Peng, Reury Perng Perng, Tsang Wu Liu, Jacqueline Ming-Liu, Kuang Yao Yang
Publikováno v:
Chest. 117:1583-1589
Study objective: Vinorelbine and gemcitabine are two active single agents used in the treatment of non-small cell lung cancer (NSCLC). A clinical trial was conducted to evaluate the efficacy and toxicity of vinorelbine plus gemcitabine in patients wi
Publikováno v:
Chest. 100:406-409
We evaluated the pharmacokinetics of a single 200-mg dose of ciprofloxacin, administered as a 30-minute infusion, into pleural exudate in five elderly patients with empyema thoracis. Ciprofloxacin was measured by HPLC and the pharmacokinetic paramete
Publikováno v:
Chest. 129(4)
Docetaxel has shown activity in the second-line treatment of non-small cell lung cancer (NSCLC). Phase II studies have suggested that weekly therapy with docetaxel probably has a better toxicity profile than the conventional schedule of once every 3
Autor:
Ingrid Hings, Chrisostomos Kouroukis
Publikováno v:
Chest. 112(3)
Vinorelbine tartrate (Navelbine [Burroughs Wellcome; Research Triangle Park, NC; Pierre Fabre Medicament; Paris, France]) is used in the treatment of non-small cell lung cancer (NSCLC), breast cancer, and some gynecologic malignant neoplasms. The rep
Pamidronate Results in Symptom Control of Hypertrophic Pulmonary Osteoarthropathy in Cystic Fibrosis
Autor:
Luke A. Garske, Scott C. Bell
Publikováno v:
Chest. 121:1363-1364
Hypertrophic pulmonary osteoarthropathy (HPOA) may complicate the advanced lung disease that is associated with cystic fibrosis, resulting in severe joint pain and early-morning stiffness. Symptoms are usually controlled with the administration of no